CNS Co (TSE:4076) Peter Lynch Fair Value: N/A (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4076 CNS Co Ltd TSE:4076
87 GF Score
Price 円1,815.00
GF Value 円1,859.61
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is CNS Co Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for CNS Co's Peter Lynch Fair Value or its related term are showing as below:

TSE:4076' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.56   Med: 1.06   Max: 1.72
Current: 1.72


During the past 8 years, the highest Price to Peter Lynch Fair Value Ratio of CNS Co was 1.72. The lowest was 0.56. And the median was 1.06.


TSE:4076's Price-to-Peter-Lynch-Fair-Value is ranked worse than
67.11% of 678 companies
in the Software industry
Industry Median: 1.225 vs TSE:4076: 1.72

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


CNS Co  (TSE:4076) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

CNS Co's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=1815.00/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CNS Co Peter Lynch Fair Value Related Terms


CNS Co Peter Lynch Fair Value Historical Data

* Premium members only.

The historical data trend for CNS Co's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CNS Co Peter Lynch Fair Value Chart

CNS Co Annual Data
Trend May19 May20 May21 May22 May23 May24 May25 May26
Peter Lynch Fair Value
Get a 7-Day Free Trial 0.00 0.00 3,028.63 0.00 1,052.37

CNS Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1,052.37

TSE:4076 vs IBM, ACN, FISV: Peter Lynch Fair Value Comparison

For the Information Technology Services subindustry, CNS Co's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CNS Co Price-to-Peter-Lynch-Fair-Value vs Software Industry

For the Software industry and Technology sector, CNS Co's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where CNS Co's Price-to-Peter-Lynch-Fair-Value falls into.


TSE:4076
87GF Score
CNS Co Ltd TSE:4076
Peter Lynch Fair Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CNS Co Peter Lynch Fair Value Calculation

CNS Co's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *146.377
=N/A

CNS Co's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was 円146.38.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.

Is CNS Co (TSE:4076) Overvalued in 2026?

Based on GuruFocus' analysis, CNS Co stock appears to be undervalued. The current stock price of 円1,815.00 is trading 2.4% below its estimated GF Value™ of 円1,859.61. GuruFocus considers CNS Co to be Fairly Valued.

Key valuation signals for TSE:4076:

  • Peter Lynch Fair Value: N/A
  • GF Value™: 円1,859.61 vs. price of 円1,815.00 (2.4% below fair value)
  • GF Score™: 87/100 with 3 warning signs

No single metric tells the full story. See the TSE:4076 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CNS Co Business Description

Address 1-5-5 Ebisu Minami, 9th Floor, JR Ebisu Building, Shibuya-ku, Tokyo, JPN, 150-0022
CNS Co Ltd is an information technology solutions company engaged in providing system engineering services. The company offers various solutions to its clients such as consulting services related to digital transformation, data analysis solutions, business system integration, and the implementation, construction, and operation of optimal system infrastructure.
87GF Score

Get the complete analysis for TSE:4076

Peter Lynch Fair Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,815.00
Price
円1,859.61
GF Value